new drug for metastatic breast cancer called Xeloda (zah-LOE-duh, capecitabine)

Roche is marketing a new drug for metastatic breast cancercalled Xeloda (zah-LOE-duh, capecitabine).

It'll be out first in the U.S...later in Canada.

Xeloda is a prodrug of 5-FU (5-fluorouracil). It'smetabolized to 5-FU by enzymes in tumour cells.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote